BSACI guideline for the management of chronic urticaria and angioedema
- PMID: 25711134
- DOI: 10.1111/cea.12494
BSACI guideline for the management of chronic urticaria and angioedema
Abstract
This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well as on expert opinion and is aimed at both adult physicians and paediatricians practising in allergy. The recommendations are evidence graded. During the development of these guidelines, all BSACI members were included in the consultation process using a Web-based system. Their comments and suggestions were carefully considered by the Standards of Care Committee. Where evidence was lacking, a consensus was reached by the experts on the committee. Included in this management guideline are clinical classification, aetiology, diagnosis, investigations, treatment guidance with special sections on children with urticaria and the use of antihistamines in women who are pregnant or breastfeeding. Finally, we have made recommendations for potential areas of future research.
Keywords: BSACI; IgE; Urticaria; adult; allergy; angioedema; anti-IgE; antihistamine; auto-antibody; autoimmune; breastfeeding; child; epidemiology; guideline; hypothyroidism; management; paraprotein; pregnancy.
© 2015 John Wiley & Sons Ltd.
Comment in
- 
  
  Classification of angioedema by endotypes.Clin Exp Allergy. 2015 Jun;45(6):1142-3. doi: 10.1111/cea.12551. Clin Exp Allergy. 2015. PMID: 25981351 No abstract available.
- 
  
  Doxepin may be a useful pharmacotherapeutic agent in chronic urticaria.Clin Exp Allergy. 2015 Aug;45(8):1370. doi: 10.1111/cea.12580. Clin Exp Allergy. 2015. PMID: 26040550 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
        